Metavia Stock Today
| MTVA Stock | 2.60 0.21 7.47% |
PerformanceWeakest
| Odds Of DistressLow
|
MetaVia is trading at 2.60 as of the 27th of January 2026, a 7.47% down since the beginning of the trading day. The stock's open price was 2.81. MetaVia has about a 24 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 29th of October 2025 and ending today, the 27th of January 2026. Click here to learn more.
Moving together with MetaVia Stock
Moving against MetaVia Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
MetaVia Stock Highlights
| President CEO | HyungHeon Kim |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
MetaVia (MTVA) is traded on NASDAQ Exchange in USA and employs 9 people. MetaVia is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.38 M. MetaVia conducts business under Biotechnology sector and is part of Health Care industry. The entity has 3.32 M outstanding shares of which 19.68 K shares are now shorted by private and institutional investors with about 0.08 trading days to cover.
MetaVia generates negative cash flow from operations
Check MetaVia Probability Of Bankruptcy
Ownership AllocationMetaVia holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.
Check MetaVia Ownership Details
MetaVia Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. MetaVia market risk premium is the additional return an investor will receive from holding MetaVia long position in a well-diversified portfolio.
| Mean Deviation | 7.64 | |||
| Standard Deviation | 11.25 | |||
| Variance | 126.67 | |||
| Risk Adjusted Performance | (0.1) |
MetaVia Stock Against Markets
MetaVia Corporate Management
| Michael Pine | Senior Advisor | Profile | |
| Marshall Woodworth | Chief Officer | Profile | |
| Christopher MD | Consulting Advisor | Profile | |
| Robert Homolka | Senior Operations | Profile | |
| MiKyung Kim | Chief Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetaVia. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private. For information on how to trade MetaVia Stock refer to our How to Trade MetaVia Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MetaVia. If investors know MetaVia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MetaVia listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of MetaVia is measured differently than its book value, which is the value of MetaVia that is recorded on the company's balance sheet. Investors also form their own opinion of MetaVia's value that differs from its market value or its book value, called intrinsic value, which is MetaVia's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MetaVia's market value can be influenced by many factors that don't directly affect MetaVia's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MetaVia's value and its price as these two are different measures arrived at by different means. Investors typically determine if MetaVia is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MetaVia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.